Skip to content
  • Provider Portal
  • Patient Portal

800.850.4306

Medication List
How to Prescribe
Suggested Search
    • About Us
      • Who We Are
      • Leadership
      • Accreditations
      • Careers
    • News & Insights
      • News
      • Our Stories
      • Events
    • Contact Us
    • About Us
      • Who We Are
      • Leadership
      • Accreditations
      • Careers
    • News & Insights
      • News
      • Our Stories
      • Events
    • Contact Us
    • Oncology
      • Oncology Provider Support
      • Oncology Clinical Support
    • Rare & Orphan Diseases
      • Rare Disease Provider Support
      • Rare Disease Clinical Support
    • Cell & Gene Therapy
      • InspiroCare Hub Services
      • Specialty Pharmacy for CGT
    • Hub Services
      • Access & Reimbursement
      • Affordability Support
      • Case Management & Adherence
      • Non-Commercial Dispensing
      • Provider Engagement
      • Biopharma Reporting & Insights
      • Technology & Integration
    • Patients
      • Oncology
      • Rare and Orphan Care
      • Cell and Gene Therapy
      • Financial Assistance
      • Patient Advocacy Groups
      • Community Resources
      • Frequently Asked Questions
    • Providers
      • How to Prescribe
      • Specialty Drugs List
      • Provider Services
      • Benefits Investigation
      • Prior Authorization Support
      • Patient Affordability Support
      • Provider Clinical Support
      • Provider FAQs
    • Oncology
      • Oncology Provider Support
      • Oncology Clinical Support
    • Rare & Orphan Diseases
      • Rare Disease Provider Support
      • Rare Disease Clinical Support
    • Cell & Gene Therapy
      • InspiroCare Hub Services
      • Specialty Pharmacy for CGT
    • Hub Services
      • Access & Reimbursement
      • Affordability Support
      • Case Management & Adherence
      • Non-Commercial Dispensing
      • Provider Engagement
      • Biopharma Reporting & Insights
      • Technology & Integration
    • Patients
      • Oncology
      • Rare and Orphan Care
      • Cell and Gene Therapy
      • Financial Assistance
      • Patient Advocacy Groups
      • Community Resources
      • Frequently Asked Questions
    • Providers
      • How to Prescribe
      • Specialty Drugs List
      • Provider Services
      • Benefits Investigation
      • Prior Authorization Support
      • Patient Affordability Support
      • Provider Clinical Support
      • Provider FAQs
    • Oncology
      • Oncology Provider Support
      • Oncology Clinical Support
    • Rare & Orphan Diseases
      • Rare Disease Provider Support
      • Rare Disease Clinical Support
    • Cell & Gene Therapy
      • InspiroCare Hub Services
      • Specialty Pharmacy for CGT
    • Hub Services
      • Access & Reimbursement
      • Affordability Support
      • Case Management & Adherence
      • Non-Commercial Dispensing
      • Provider Engagement
      • Biopharma Reporting & Insights
      • Technology & Integration
    • Patients
      • Oncology
      • Rare and Orphan Care
      • Cell and Gene Therapy
      • Financial Assistance
      • Patient Advocacy Groups
      • Community Resources
      • Frequently Asked Questions
    • Providers
      • How to Prescribe
      • Specialty Drugs List
      • Provider Services
      • Benefits Investigation
      • Prior Authorization Support
      • Patient Affordability Support
      • Provider Clinical Support
      • Provider FAQs
    Medication list
    How to Prescribe
    Suggested Keywords

      Category: Video Transcripts

      Video Transcript: Oral Oncolytics Versus Intravenous: Safety and Efficacy

      This transcript compares oral and intravenous oncolytics, with a focus on adherence, patient education, and practical considerations that influence safety and effectiveness.

      Video Transcript: Developing Clinical Trials for Newly Diagnosed Disease

      Key opinion leaders review emerging clinical trial data and treatment considerations for patients with newly diagnosed chronic lymphocytic leukemia.

      Video Transcript: Limited-Duration Therapy Based on MRD Testing

      Experts discuss how minimum residual disease testing may influence limited-duration therapy decisions in chronic lymphocytic leukemia and where the current evidence remains more established or uncertain.

      ← Previous

      11800 Weston Parkway
      Cary, NC 27513
      T. 800.850.4306

      Legal

      • Privacy Notice
      • Terms of Use
      • Nondiscrimination Notice
      • Change Healthcare HIPAA Substitute Notice
      • Privacy Notice
      • Terms of Use
      • Nondiscrimination Notice
      • Change Healthcare HIPAA Substitute Notice

      For Patients

      • Privacy Practices (PDF)
      • Patient’s Rights (PDF)
      • Privacy Practices (PDF)
      • Patient’s Rights (PDF)

      Learn more about McKesson

      URAC Specialty Pharmacy Accreditation
      Specialty Pharmacy
      07/01/2029
      • Home
      • Patients
      • Providers
      • Payers
      • Biopharma
        • Oncology
        • Rare and Orphan Diseases
        • Cell & Gene Therapy
        • Hub Services
      • News
      • Careers
      • About Us
      • Contact
      • Resources
      • How to Prescribe
      • Home
      • Patients
      • Providers
      • Payers
      • Biopharma
        • Oncology
        • Rare and Orphan Diseases
        • Cell & Gene Therapy
        • Hub Services
      • News
      • Careers
      • About Us
      • Contact
      • Resources
      • How to Prescribe

      © 2025 McKesson Corporation. All Rights Reserved.